Harrow, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2022 Annual Meeting of Stockholders held by Harrow Health, Inc. on June 9, 2022. The company is incorporated in Delaware and trades on the NASDAQ Global Market under the symbols HROW (Common Stock) and HROWL (8.625% Senior Notes due 2026).
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
At the Annual Meeting, 19,375,716 shares were present or represented by proxy out of 27,031,127 shares entitled to vote. All three proposals submitted to stockholders were approved:
- Proposal 1 (Election of Directors): Six director nominees were elected. While all were approved, the number of "Withheld" votes varied significantly among candidates, ranging from 23,201 for Mark L. Baum to 583,568 for R. Lawrence Van Horn. There were 5,481,190 broker non-votes for this proposal.
- Proposal 2 (Ratification of Auditors): Stockholders ratified KMJ Corbin and Company, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022. The vote was 19,111,223 For, 230,446 Against, and 34,047 Abstain.
- Proposal 3 (Executive Compensation): Stockholders approved the advisory compensation of named executive officers. The vote was 13,569,789 For, 284,580 Against, and 40,157 Abstain.
Guidance, Outlook, and Risks
This filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It strictly reports the outcome of the shareholder vote.
Key Facts for Investor Verification
- Verify the specific reasons for the higher "Withheld" vote count for director R. Lawrence Van Horn compared to other nominees.
- Confirm the total number of shares outstanding and the percentage of ownership held by institutional investors to contextualize the 5.48 million broker non-votes.
- Review the company's most recent 10-K or 10-Q for actual financial performance metrics, as this 8-K contains none.
- Monitor the company's status regarding its 8.625% Senior Notes due 2026 (HROWL) for any upcoming covenant compliance or maturity events.